[Depression of protective mechanisms against ectromelia virus infection in tumor-bearing mice and its prevention by PSK]. 1984

M Taniguchi, and S Tsuru, and H Kitani, and Y Zinnaka, and K Nomoto

Effector mechanisms responsible for protection against ectromelia virus (EMV) including antiviral activity of non-immune macrophages, cytotoxic T cells, antiviral antibody, delayed footpad reaction to viral antigen and interferon induction after viral infection were depressed in BALB/c mice bearing syngeneic Meth A tumors. The degree of viral growth correlated well with the depression of delayed footpad reaction, antibody production and interferon induction. But a control level of these elements could be obtained by pretreatment of tumor-bearing mice, with PSK Cytotoxic activity may not be the principal effector, since cytotoxicity was induced in both normal and tumor-bearing mice to almost the same extent but an explosive viral growth was observed only in the latter. These results suggest that PSK was responsible for restoring the depressed antiviral protective immunity to normal levels in tumor-bearing animals.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011213 Poxviridae Infections Virus diseases caused by the POXVIRIDAE. Milker's Nodes,Orthopoxvirus Infection,Poxvirus Infections,Infections, Poxviridae,Infections, Poxvirus,Infection, Orthopoxvirus,Infection, Poxviridae,Infection, Poxvirus,Milker Nodes,Milker's Node,Milkers Nodes,Orthopoxvirus Infections,Poxviridae Infection,Poxvirus Infection
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D004482 Ectromelia, Infectious A viral infection of mice, causing edema and necrosis followed by limb loss. Mousepox,Infectious Ectromelia,Mouse Pox
D005354 Fibrosarcoma A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed) Fibrosarcomas
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants

Related Publications

M Taniguchi, and S Tsuru, and H Kitani, and Y Zinnaka, and K Nomoto
August 1977, Gan,
M Taniguchi, and S Tsuru, and H Kitani, and Y Zinnaka, and K Nomoto
January 1979, Advances in experimental medicine and biology,
M Taniguchi, and S Tsuru, and H Kitani, and Y Zinnaka, and K Nomoto
May 1983, Journal of clinical & laboratory immunology,
M Taniguchi, and S Tsuru, and H Kitani, and Y Zinnaka, and K Nomoto
August 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
M Taniguchi, and S Tsuru, and H Kitani, and Y Zinnaka, and K Nomoto
October 2003, Cancer biotherapy & radiopharmaceuticals,
M Taniguchi, and S Tsuru, and H Kitani, and Y Zinnaka, and K Nomoto
January 1987, Anticancer research,
M Taniguchi, and S Tsuru, and H Kitani, and Y Zinnaka, and K Nomoto
September 1983, Infection and immunity,
M Taniguchi, and S Tsuru, and H Kitani, and Y Zinnaka, and K Nomoto
December 1984, Journal of clinical & laboratory immunology,
M Taniguchi, and S Tsuru, and H Kitani, and Y Zinnaka, and K Nomoto
June 1980, Biken journal,
M Taniguchi, and S Tsuru, and H Kitani, and Y Zinnaka, and K Nomoto
January 1987, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!